These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10533845)

  • 1. Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzer.
    Kleinveld HA; Andersson NE; van Voorthuizen H; den Hartog J; de Groot PG
    Scand J Clin Lab Invest; 1999 Aug; 59(5):335-41. PubMed ID: 10533845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of clotting factor VIII activity in mammals using the one-stage clotting and the chromogenic methods].
    Lutze G; Lutze G; Kutschmann K; Schröpel M
    Berl Munch Tierarztl Wochenschr; 2002; 115(7-8):297-302. PubMed ID: 12174728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A.
    Novembrino C; Boscolo Anzoletti M; Mancuso ME; Shinohara S; Peyvandi F
    Haemophilia; 2019 May; 25(3):521-526. PubMed ID: 31044485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of a chromogenic substrate method for determination of factor VIII activity.
    Rosén S; Andersson M; Blombäck M; Hägglund U; Larrieu MJ; Wolf M; Boyer C; Rothschild C; Nilsson IM; Sjörin E
    Thromb Haemost; 1985 Dec; 54(4):818-23. PubMed ID: 3937277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrophotometric method for the assay of human blood coagulation factor VIII.
    van Dieijen G; van Dieijen-Visser MP; Franssen J; Hemker HC
    Haemostasis; 1987; 17(1-2):14-24. PubMed ID: 3110024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of Revohem
    Suzuki A; Suzuki N; Kanematsu T; Shinohara S; Arai N; Kikuchi R; Matsushita T
    Int J Lab Hematol; 2019 Oct; 41(5):664-670. PubMed ID: 31271527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effective approach to factor assay calibration using a truncated live calibration curve.
    Guy S; Sermon-Cadd AM; Shepherd FM; Kitchen S; Bowyer AE
    Int J Lab Hematol; 2019 Oct; 41(5):679-683. PubMed ID: 31421012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-stage vs. chromogenic assays in haemophilia A.
    Potgieter JJ; Damgaard M; Hillarp A
    Eur J Haematol; 2015 Feb; 94 Suppl 77():38-44. PubMed ID: 25560793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP.
    Appert-Flory A; Fischer F; Jambou D; Toulon P
    Thromb Res; 2007; 120(5):733-43. PubMed ID: 17275069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of an automated chromogenic assay of potency of factor VIII in commercial concentrates.
    Collazo V; Alonso C; Frutos G
    Int J Lab Hematol; 2013 Feb; 35(1):38-45. PubMed ID: 22862836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories.
    Sommer JM; Moore N; McGuffie-Valentine B; Bardan S; Buyue Y; Kamphaus GD; Konkle BA; Pierce GF
    Haemophilia; 2014 Mar; 20(2):294-300. PubMed ID: 24261554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level.
    Baig MA; Swamy KB
    Indian J Pathol Microbiol; 2021; 64(1):123-127. PubMed ID: 33433421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
    Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
    Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A.
    Rodgers S; Duncan E
    Methods Mol Biol; 2017; 1646():265-276. PubMed ID: 28804835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a simple chromogenic factor VIII assay for clinical use.
    Wagenvoord RJ; Hendrix HH; Hemker HC
    Haemostasis; 1989; 19(4):196-204. PubMed ID: 2509307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromogenic substrates for activated partial thromboplastin time testing: are they worth using?
    Tripodi A
    Ric Clin Lab; 1989; 19(4):355-8. PubMed ID: 2517351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Chromogenic Factor VIII Assay Compared with One-Stage Clotting Assay.
    Akkaya E; Hatiboglu S; Koc B; Genc S; Unuvar A; Karaman S; Omer B; Karakas Z; Zulfikar B
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.